{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T13:38:37Z","timestamp":1791121117097,"version":"4.1.0"},"reference-count":64,"publisher":"American Society of Hematology","issue":"8","content-domain":{"domain":["ashpublications.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2006,4,15]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>We previously identified a small number of genes using cDNA arrays that accurately diagnosed patients with Se\u0301zary Syndrome (SS), the erythrodermic and leukemic form of cutaneous T-cell lymphoma (CTCL). We now report the development of a quantitative real-time polymerase chain reaction (qRT-PCR) assay that uses expression values for just 5 of those genes: STAT4, GATA-3, PLS3, CD1D, and TRAIL. qRT-PCR data from peripheral blood mononuclear cells (PBMCs) accurately classified 88% of 17 patients with high blood tumor burden and 100% of 12 healthy controls in the training set using Fisher linear discriminant analysis (FLDA). The same 5 genes were then assayed on 56 new samples from 49 SS patients with blood tumor burdens of 5% to 99% and 69 samples from 65 new healthy controls. The average accuracy over 1000 resamplings was 90% using FLDA and 88% using support vector machine (SVM). We also tested the classifier on 14 samples from patients with CTCL with no detectable peripheral involvement and 3 patients with atopic dermatitis with severe erythroderma. The accuracy was 100% in identifying these samples as non-SS patients. These results are the first to demonstrate that gene expression profiling by quantitative PCR on a selected number of critical genes can be employed to molecularly diagnosis SS.<\/jats:p>","DOI":"10.1182\/blood-2005-07-2813","type":"journal-article","created":{"date-parts":[[2006,1,11]],"date-time":"2006-01-11T01:48:50Z","timestamp":1136944130000},"page":"3189-3196","update-policy":"https:\/\/doi.org\/10.1182\/blood.2019cm0000","source":"Crossref","is-referenced-by-count":91,"title":["Quantitative PCR on 5 genes reliably identifies CTCL patients with 5% to 99% circulating tumor cells with 90% accuracy"],"prefix":"10.1182","volume":"107","author":[{"given":"Michael","family":"Nebozhyn","sequence":"first","affiliation":[{"name":"From the Wistar Institute, Philadelphia, PA; Department of Dermatology, The University of Pennsylvania School of Medicine, Philadelphia; Department of Dermatology, Johns Hopkins Medical Institutions, Baltimore, MD; Fox Chase Cancer Center, Philadelphia, PA; and Department of Dermatology, Yale University, New Haven, CT."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrey","family":"Loboda","sequence":"additional","affiliation":[{"name":"From the Wistar Institute, Philadelphia, PA; Department of Dermatology, The University of Pennsylvania School of Medicine, Philadelphia; Department of Dermatology, Johns Hopkins Medical Institutions, Baltimore, MD; Fox Chase Cancer Center, Philadelphia, PA; and Department of Dermatology, Yale University, New Haven, CT."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laszlo","family":"Kari","sequence":"additional","affiliation":[{"name":"From the Wistar Institute, Philadelphia, PA; Department of Dermatology, The University of Pennsylvania School of Medicine, Philadelphia; Department of Dermatology, Johns Hopkins Medical Institutions, Baltimore, MD; Fox Chase Cancer Center, Philadelphia, PA; and Department of Dermatology, Yale University, New Haven, CT."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alain H.","family":"Rook","sequence":"additional","affiliation":[{"name":"From the Wistar Institute, Philadelphia, PA; Department of Dermatology, The University of Pennsylvania School of Medicine, Philadelphia; Department of Dermatology, Johns Hopkins Medical Institutions, Baltimore, MD; Fox Chase Cancer Center, Philadelphia, PA; and Department of Dermatology, Yale University, New Haven, CT."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric C.","family":"Vonderheid","sequence":"additional","affiliation":[{"name":"From the Wistar Institute, Philadelphia, PA; Department of Dermatology, The University of Pennsylvania School of Medicine, Philadelphia; Department of Dermatology, Johns Hopkins Medical Institutions, Baltimore, MD; Fox Chase Cancer Center, Philadelphia, PA; and Department of Dermatology, Yale University, New Haven, CT."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stuart","family":"Lessin","sequence":"additional","affiliation":[{"name":"From the Wistar Institute, Philadelphia, PA; Department of Dermatology, The University of Pennsylvania School of Medicine, Philadelphia; Department of Dermatology, Johns Hopkins Medical Institutions, Baltimore, MD; Fox Chase Cancer Center, Philadelphia, PA; and Department of Dermatology, Yale University, New Haven, CT."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carole","family":"Berger","sequence":"additional","affiliation":[{"name":"From the Wistar Institute, Philadelphia, PA; Department of Dermatology, The University of Pennsylvania School of Medicine, Philadelphia; Department of Dermatology, Johns Hopkins Medical Institutions, Baltimore, MD; Fox Chase Cancer Center, Philadelphia, PA; and Department of Dermatology, Yale University, New Haven, CT."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard","family":"Edelson","sequence":"additional","affiliation":[{"name":"From the Wistar Institute, Philadelphia, PA; Department of Dermatology, The University of Pennsylvania School of Medicine, Philadelphia; Department of Dermatology, Johns Hopkins Medical Institutions, Baltimore, MD; Fox Chase Cancer Center, Philadelphia, PA; and Department of Dermatology, Yale University, New Haven, CT."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Calen","family":"Nichols","sequence":"additional","affiliation":[{"name":"From the Wistar Institute, Philadelphia, PA; Department of Dermatology, The University of Pennsylvania School of Medicine, Philadelphia; Department of Dermatology, Johns Hopkins Medical Institutions, Baltimore, MD; Fox Chase Cancer Center, Philadelphia, PA; and Department of Dermatology, Yale University, New Haven, CT."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Malik","family":"Yousef","sequence":"additional","affiliation":[{"name":"From the Wistar Institute, Philadelphia, PA; Department of Dermatology, The University of Pennsylvania School of Medicine, Philadelphia; Department of Dermatology, Johns Hopkins Medical Institutions, Baltimore, MD; Fox Chase Cancer Center, Philadelphia, PA; and Department of Dermatology, Yale University, New Haven, CT."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lalitha","family":"Gudipati","sequence":"additional","affiliation":[{"name":"From the Wistar Institute, Philadelphia, PA; Department of Dermatology, The University of Pennsylvania School of Medicine, Philadelphia; Department of Dermatology, Johns Hopkins Medical Institutions, Baltimore, MD; Fox Chase Cancer Center, Philadelphia, PA; and Department of Dermatology, Yale University, New Haven, CT."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meiling","family":"Shang","sequence":"additional","affiliation":[{"name":"From the Wistar Institute, Philadelphia, PA; Department of Dermatology, The University of Pennsylvania School of Medicine, Philadelphia; Department of Dermatology, Johns Hopkins Medical Institutions, Baltimore, MD; Fox Chase Cancer Center, Philadelphia, PA; and Department of Dermatology, Yale University, New Haven, CT."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael K.","family":"Showe","sequence":"additional","affiliation":[{"name":"From the Wistar Institute, Philadelphia, PA; Department of Dermatology, The University of Pennsylvania School of Medicine, Philadelphia; Department of Dermatology, Johns Hopkins Medical Institutions, Baltimore, MD; Fox Chase Cancer Center, Philadelphia, PA; and Department of Dermatology, Yale University, New Haven, CT."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Louise C.","family":"Showe","sequence":"additional","affiliation":[{"name":"From the Wistar Institute, Philadelphia, PA; Department of Dermatology, The University of Pennsylvania School of Medicine, Philadelphia; Department of Dermatology, Johns Hopkins Medical Institutions, Baltimore, MD; Fox Chase Cancer Center, Philadelphia, PA; and Department of Dermatology, Yale University, New Haven, CT."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"234","reference":[{"key":"2019111712372670300_REF1","unstructured":"Kim YH, Hoppe RT. Mycosis fungoides and the Sezary syndrome. Semin Oncol. 1999;26: 276-289."},{"key":"2019111712372670300_REF2","doi-asserted-by":"crossref","unstructured":"Kim YH, Jensen RA, Watanabe GL, Varghese A, Hoppe RT. Clinical stage IA (limited patch and plaque) mycosis fungoides: a long-term outcome analysis. Arch Dermatol. 1996;132: 1309-1313.","DOI":"10.1001\/archderm.1996.03890350051009"},{"key":"2019111712372670300_REF3","doi-asserted-by":"crossref","unstructured":"Diamandidou E, Cohen PR, Kurzrock R. Mycosis fungoides and Sezary syndrome. Blood. 1996;88: 2385-2409.","DOI":"10.1182\/blood.V88.7.2385.bloodjournal8872385"},{"key":"2019111712372670300_REF4","doi-asserted-by":"crossref","unstructured":"Duvic M. Treatment of cutaneous T-cell lymphoma from a dermatologist's perspective. Clin Lymphoma. 2000;1(suppl 1): S15-S20.","DOI":"10.3816\/CLM.2000.s.003"},{"key":"2019111712372670300_REF5","doi-asserted-by":"crossref","unstructured":"Foss FM. An oncologist's approach to therapy for cutaneous T-cell lymphoma. Clin Lymphoma. 2000;1(suppl 1): S9-S14.","DOI":"10.3816\/CLM.2000.s.002"},{"key":"2019111712372670300_REF6","doi-asserted-by":"crossref","unstructured":"Kim YH, Bishop K, Varghese A, Hoppe RT. Prognostic factors in erythrodermic mycosis fungoides and the Sezary syndrome. Arch Dermatol. 1995;131: 1003-1008.","DOI":"10.1001\/archderm.1995.01690210033005"},{"key":"2019111712372670300_REF7","unstructured":"Willemze R, Kerl H, Sterry W, et al. EORTC classification for primary cutaneous lymphomas: a proposal from the Cutaneous Lymphoma Study Group of the European Organization for Research and Treatment of Cancer. Blood. 1997;90: 354-371."},{"key":"2019111712372670300_REF8","doi-asserted-by":"crossref","unstructured":"Novelli M, Savoia P, Fierro MT, Verrone A, Quaglino P, Bernengo MG. Keratinocytes express dipeptidyl-peptidase IV (CD26) in benign and malignant skin diseases. Br J Dermatol. 1996;134: 1052-1056.","DOI":"10.1111\/j.1365-2133.1996.tb07941.x"},{"key":"2019111712372670300_REF9","doi-asserted-by":"crossref","unstructured":"Bernengo MG, Novelli M, Quaglino P, et al. The relevance of the CD4+ CD26-subset in the identification of circulating Sezary cells. Br J Dermatol. 2001;144: 125-135.","DOI":"10.1046\/j.1365-2133.2001.04014.x"},{"key":"2019111712372670300_REF10","doi-asserted-by":"crossref","unstructured":"Jones D, Dang NH, Duvic M, Washington LT, Huh YO. Absence of CD26 expression is a useful marker for diagnosis of T-cell lymphoma in peripheral blood. Am J Clin Pathol. 2001;115: 885-892.","DOI":"10.1309\/U1Y6-J4AG-5M4M-7AYV"},{"key":"2019111712372670300_REF11","doi-asserted-by":"crossref","unstructured":"Russell-Jones R. Immunophenotyping of Sezary cells. Br J Dermatol. 2001;144: 2-3.","DOI":"10.1046\/j.1365-2133.2001.04065.x"},{"key":"2019111712372670300_REF12","doi-asserted-by":"crossref","unstructured":"Bernengo MG, Quaglino P, Novelli M, et al. Prognostic factors in Sezary syndrome: a multivariate analysis of clinical, haematological and immunological features. Ann Oncol. 1998;9: 857-863.","DOI":"10.1023\/A:1008397323199"},{"key":"2019111712372670300_REF13","doi-asserted-by":"crossref","unstructured":"Kari L, Loboda A, Nebozhyn M, et al. Classification and prediction of survival in patients with the leukemic phase of cutaneous T cell lymphoma. J Exp Med. 2003;197: 1477-1488.","DOI":"10.1084\/jem.20021726"},{"key":"2019111712372670300_REF14","doi-asserted-by":"crossref","unstructured":"Hastie T, Buja A, Tibshirani R. Penalized discriminant analysis. Ann Stat. 1995;23: 73-102.","DOI":"10.1214\/aos\/1176324456"},{"key":"2019111712372670300_REF15","doi-asserted-by":"crossref","unstructured":"Raychaudhuri S, Sutphin PD, Chang JT, Altman RB. Basic microarray analysis: grouping and feature reduction. Trends Biotechnol. 2001;19: 189-193.","DOI":"10.1016\/S0167-7799(01)01599-2"},{"key":"2019111712372670300_REF16","doi-asserted-by":"crossref","unstructured":"Raddatz G, Dehio M, Meyer TF, Dehio C. Prime-Array: genome-scale primer design for DNA-microarray construction. Bioinformatics. 2001;17: 98-99.","DOI":"10.1093\/bioinformatics\/17.1.98"},{"key":"2019111712372670300_REF17","doi-asserted-by":"crossref","unstructured":"Sorlie T, Perou CM, Tibshirani R, et al. Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications. Proc Natl Acad Sci U S A. 2001;98: 10869-10874.","DOI":"10.1073\/pnas.191367098"},{"key":"2019111712372670300_REF18","doi-asserted-by":"crossref","unstructured":"Staudt LM. Gene expression profiling of lymphoid malignancies. Annu Rev Med. 2002;53: 303-318.","DOI":"10.1146\/annurev.med.53.082901.103941"},{"key":"2019111712372670300_REF19","doi-asserted-by":"crossref","unstructured":"Yeoh EJ, Ross ME, Shurtleff SA, et al. Classification, subtype discovery, and prediction of outcome in pediatric acute lymphoblastic leukemia by gene expression profiling. Cancer Cell. 2002;1: 133-143.","DOI":"10.1016\/S1535-6108(02)00032-6"},{"key":"2019111712372670300_REF20","doi-asserted-by":"crossref","unstructured":"Beer DG, Kardia SL, Huang CC, et al. Gene-expression profiles predict survival of patients with lung adenocarcinoma. Nat Med. 2002;8: 816-824.","DOI":"10.1038\/nm733"},{"key":"2019111712372670300_REF21","doi-asserted-by":"crossref","unstructured":"Rosenwald A, Wright G, Chan WC, et al. The use of molecular profiling to predict survival after chemotherapy for diffuse large-B-cell lymphoma. N Engl J Med. 2002;346: 1937-1947.","DOI":"10.1056\/NEJMoa012914"},{"key":"2019111712372670300_REF22","doi-asserted-by":"crossref","unstructured":"Spang R. Diagnostic signatures from microarrays: a bioinformatics concept for personalized medicine. Biosilico. 2003;1: 64-68.","DOI":"10.1016\/S1478-5382(03)02329-1"},{"key":"2019111712372670300_REF23","doi-asserted-by":"crossref","unstructured":"Van't Veer LJ, De Jong D. The microarray way to tailored cancer treatment. Nat Med. 2002;8: 13-14.","DOI":"10.1038\/nm0102-13"},{"key":"2019111712372670300_REF24","doi-asserted-by":"crossref","unstructured":"Fisher RA. The statistical utilization of multiple measurements. Ann Eugen. 1938;8: 376-386.","DOI":"10.1111\/j.1469-1809.1938.tb02189.x"},{"key":"2019111712372670300_REF25","doi-asserted-by":"crossref","unstructured":"Vapnik V, Chapelle O. Bounds on error expectation for support vector machines. Neural Comput. 2000;12: 2013-2036.","DOI":"10.1162\/089976600300015042"},{"key":"2019111712372670300_REF26","doi-asserted-by":"crossref","unstructured":"Ambroise C, McLachlan GJ. Selection bias in gene extraction on the basis of microarray gene-expression data. Proc Natl Acad Sci U S A. 2002;99: 6562-6566.","DOI":"10.1073\/pnas.102102699"},{"key":"2019111712372670300_REF27","doi-asserted-by":"crossref","unstructured":"Virok D, Loboda A, Kari L, et al. Infection of U937 monocytic cells with Chlamydia pneumoniae induces extensive changes in host cell gene expression. J Infect Dis. 2003;188: 1310-1321.","DOI":"10.1086\/379047"},{"key":"2019111712372670300_REF28","doi-asserted-by":"crossref","unstructured":"Lin CS, Aebersold RH, Kent SB, Varma M, Leavitt J. Molecular cloning and characterization of plastin, a human leukocyte protein expressed in transformed human fibroblasts. Mol Cell Biol. 1988;8: 4659-4668.","DOI":"10.1128\/MCB.8.11.4659"},{"key":"2019111712372670300_REF29","doi-asserted-by":"crossref","unstructured":"Lin CS, Lau A, Huynh T, Lue TF. Differential regulation of human T-plastin gene in leukocytes and non-leukocytes: identification of the promoter, enhancer, and CpG island. DNA Cell Biol. 1999;18: 27-37.","DOI":"10.1089\/104454999315592"},{"key":"2019111712372670300_REF30","unstructured":"Gordon GJ, Jensen RV, Hsiao LL, et al. Translation of microarray data into clinically relevant cancer diagnostic tests using gene expression ratios in lung cancer and mesothelioma. Cancer Res. 2002;62: 4963-4967."},{"key":"2019111712372670300_REF31","doi-asserted-by":"crossref","unstructured":"Lossos IS, Czerwinski DK, Alizadeh AA, et al. Prediction of survival in diffuse large-B-cell lymphoma based on the expression of six genes. N Engl J Med. 2004;350: 1828-1837.","DOI":"10.1056\/NEJMoa032520"},{"key":"2019111712372670300_REF32","doi-asserted-by":"crossref","unstructured":"Rao A, Avni O. Molecular aspects of T-cell differentiation. Br Med Bull. 2000;56: 969-984.","DOI":"10.1258\/0007142001903634"},{"key":"2019111712372670300_REF33","doi-asserted-by":"crossref","unstructured":"Szabo SJ, Jacobson NG, Dighe AS, Gubler U, Murphy KM. Developmental commitment to the Th2 lineage by extinction of IL-12 signaling. Immunity. 1995;2: 665-675.","DOI":"10.1016\/1074-7613(95)90011-X"},{"key":"2019111712372670300_REF34","doi-asserted-by":"crossref","unstructured":"Nishikomori R, Usui T, Wu CY, Morinobu A, O'Shea JJ, Strober W. Activated STAT4 has an essential role in Th1 differentiation and proliferation that is independent of its role in the maintenance of IL-12R beta 2 chain expression and signaling. J Immunol. 2002;169: 4388-4398.","DOI":"10.4049\/jimmunol.169.8.4388"},{"key":"2019111712372670300_REF35","doi-asserted-by":"crossref","unstructured":"Murphy KM, Ouyang W, Szabo SJ, et al. T helper differentiation proceeds through Stat1-dependent, Stat4-dependent and Stat4-independent phases. Curr Top Microbiol Immunol. 1999;238: 13-26.","DOI":"10.1007\/978-3-662-09709-0_2"},{"key":"2019111712372670300_REF36","doi-asserted-by":"crossref","unstructured":"Showe LC, Fox FE, Williams D, Au K, Niu Z, Rook AH. Depressed IL-12-mediated signal transduction in T cells from patients with Sezary syndrome is associated with the absence of IL-12 receptor beta 2 mRNA and highly reduced levels of STAT4. J Immunol. 1999;163: 4073-4079.","DOI":"10.4049\/jimmunol.163.7.4073"},{"key":"2019111712372670300_REF37","unstructured":"Roth W, Isenmann S, Nakamura M, et al. Soluble decoy receptor 3 is expressed by malignant gliomas and suppresses CD95 ligand-induced apoptosis and chemotaxis. Cancer Res. 2001;61: 2759-2765."},{"key":"2019111712372670300_REF38","doi-asserted-by":"crossref","unstructured":"Wuchter C, Krappmann D, Cai Z, et al. In vitro susceptibility to TRAIL-induced apoptosis of acute leukemia cells in the context of TRAIL receptor gene expression and constitutive NF-kappa B activity. Leukemia. 2001;15: 921-928.","DOI":"10.1038\/sj.leu.2402131"},{"key":"2019111712372670300_REF39","unstructured":"Su MW, Dorocicz I, Dragowska WH, et al. Aberrant expression of T-plastin in Sezary cells. Cancer Res. 2003;63: 7122-7127."},{"key":"2019111712372670300_REF40","doi-asserted-by":"crossref","unstructured":"Arpin M, Friederich E, Algrain M, Vernel F, Louvard D. Functional differences between L- and T-plastin isoforms. J Cell Biol. 1994;127: 1995-2008.","DOI":"10.1083\/jcb.127.6.1995"},{"key":"2019111712372670300_REF41","doi-asserted-by":"crossref","unstructured":"Daudet N, Lebart MC. Transient expression of the t-isoform of plastins\/fimbrin in the stereocilia of developing auditory hair cells. Cell Motil Cytoskeleton. 2002;53: 326-336.","DOI":"10.1002\/cm.10092"},{"key":"2019111712372670300_REF42","doi-asserted-by":"crossref","unstructured":"Samstag Y, Eibert SM, Klemke M, Wabnitz GH. Actin cytoskeletal dynamics in T lymphocyte activation and migration. J Leukoc Biol. 2003;73: 30-48.","DOI":"10.1189\/jlb.0602272"},{"key":"2019111712372670300_REF43","doi-asserted-by":"crossref","unstructured":"Lin CS, Lau A, Yeh CC, Chang CH, Lue TF. Up-regulation of L-plastin gene by testosterone in breast and prostate cancer cells: identification of three cooperative androgen receptor-binding sequences. DNA Cell Biol. 2000;19: 1-7.","DOI":"10.1089\/104454900314654"},{"key":"2019111712372670300_REF44","doi-asserted-by":"crossref","unstructured":"Otsuka M, Kato M, Yoshikawa T, et al. Differential expression of the L-plastin gene in human colorectal cancer progression and metastasis. Biochem Biophys Res Commun. 2001;289: 876-881.","DOI":"10.1006\/bbrc.2001.6047"},{"key":"2019111712372670300_REF45","doi-asserted-by":"crossref","unstructured":"Tracey L, Villuendas R, Dotor AM, et al. Mycosis fungoides shows concurrent deregulation of multiple genes involved in the TNF signaling pathway: an expression profile study. Blood. 2003;102: 1042-1050.","DOI":"10.1182\/blood-2002-11-3574"},{"key":"2019111712372670300_REF46","doi-asserted-by":"crossref","unstructured":"Miura Y, Misawa N, Maeda N, et al. Critical contribution of tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) to apoptosis of human CD4+ T cells in HIV-1-infected hu-PBL-NOD-SCID mice. J Exp Med. 2001;193: 651-660.","DOI":"10.1084\/jem.193.5.651"},{"key":"2019111712372670300_REF47","doi-asserted-by":"crossref","unstructured":"Simon AK, Williams O, Mongkolsapaya J, et al. Tumor necrosis factor-related apoptosis-inducing ligand in T cell development: sensitivity of human thymocytes. Proc Natl Acad Sci U S A. 2001;98: 5158-5163.","DOI":"10.1073\/pnas.091100398"},{"key":"2019111712372670300_REF48","unstructured":"Nguyen T, Thomas W, Zhang XD, Gray C, Hersey P. Immunologically-mediated tumour cell apoptosis: the role of TRAIL in T cell and cytokine-mediated responses to melanoma. Forum (Genova). 2000;10: 243-252."},{"key":"2019111712372670300_REF49","doi-asserted-by":"crossref","unstructured":"Burns TF, El-Deiry WS. Identification of inhibitors of TRAIL-induced death (ITIDs) in the TRAIL-sensitive colon carcinoma cell line SW480 using a genetic approach. J Biol Chem. 2001;276: 37879-37886.","DOI":"10.1074\/jbc.M103516200"},{"key":"2019111712372670300_REF50","doi-asserted-by":"crossref","unstructured":"Larribere L, Khaled M, Tartare-Deckert S, et al. PI3K mediates protection against TRAIL-induced apoptosis in primary human melanocytes. Cell Death Differ. 2004;11: 1084-1091.","DOI":"10.1038\/sj.cdd.4401475"},{"key":"2019111712372670300_REF51","doi-asserted-by":"crossref","unstructured":"Hara Y, Miura S, Komoto S, et al. Exposure to fatty acids modulates interferon production by intraepithelial lymphocytes. Immunol Lett. 2003;86: 139-148.","DOI":"10.1016\/S0165-2478(03)00007-5"},{"key":"2019111712372670300_REF52","doi-asserted-by":"crossref","unstructured":"Puduvalli VK, Sampath D, Bruner JM, Nangia J, Xu R, Kyritsis AP. TRAIL-induced apoptosis in gliomas is enhanced by Akt-inhibition and is independent of JNK activation. Apoptosis. 2005;10: 233-243.","DOI":"10.1007\/s10495-005-6078-3"},{"key":"2019111712372670300_REF53","doi-asserted-by":"crossref","unstructured":"Whang YE, Yuan XJ, Liu Y, Majumder S, Lewis TD. Regulation of sensitivity to TRAIL by the PTEN tumor suppressor. Vitam Horm. 2004;67: 409-426.","DOI":"10.1016\/S0083-6729(04)67021-X"},{"key":"2019111712372670300_REF54","doi-asserted-by":"crossref","unstructured":"Brigl M, Brenner MB. CD1: antigen presentation and T cell function. Annu Rev Immunol. 2004;22: 817-890.","DOI":"10.1146\/annurev.immunol.22.012703.104608"},{"key":"2019111712372670300_REF55","doi-asserted-by":"crossref","unstructured":"Kronenberg M. Toward an understanding of NKT cell biology: progress and paradoxes. Annu Rev Immunol. 2005;23: 877-900.","DOI":"10.1146\/annurev.immunol.23.021704.115742"},{"key":"2019111712372670300_REF56","doi-asserted-by":"crossref","unstructured":"Sugita M, Cernadas M, Brenner MB. New insights into pathways for CD1-mediated antigen presentation. Curr Opin Immunol. 2004;16: 90-95.","DOI":"10.1016\/j.coi.2003.11.014"},{"key":"2019111712372670300_REF57","doi-asserted-by":"crossref","unstructured":"Zhou D, Mattner J, Cantu C III, et al. Lysosomal glycosphingolipid recognition by NKT cells. Science. 2004;306: 1786-1789.","DOI":"10.1126\/science.1103440"},{"key":"2019111712372670300_REF58","doi-asserted-by":"crossref","unstructured":"Dhodapkar MV, Geller MD, Chang DH, et al. A reversible defect in natural killer T cell function characterizes the progression of premalignant to malignant multiple myeloma. J Exp Med. 2003;197: 1667-1676.","DOI":"10.1084\/jem.20021650"},{"key":"2019111712372670300_REF59","doi-asserted-by":"crossref","unstructured":"Fais F, Tenca C, Cimino G, et al. CD1d expression on B-precursor acute lymphoblastic leukemia subsets with poor prognosis. Leukemia. 2005;19: 551-556.","DOI":"10.1038\/sj.leu.2403671"},{"key":"2019111712372670300_REF60","doi-asserted-by":"crossref","unstructured":"Esmon CT. Structure and functions of the endothelial cell protein C receptor. Crit Care Med. 2004;32: S298-S301.","DOI":"10.1097\/01.CCM.0000126128.64614.81"},{"key":"2019111712372670300_REF61","doi-asserted-by":"crossref","unstructured":"Rook AH, Kubin M, Cassin M, et al. IL-12 reverses cytokine and immune abnormalities in Sezary syndrome. J Immunol. 1995;154: 1491-1498.","DOI":"10.4049\/jimmunol.154.3.1491"},{"key":"2019111712372670300_REF62","doi-asserted-by":"crossref","unstructured":"Rook AH, Kubin M, Fox FE, et al. The potential therapeutic role of interleukin-12 in cutaneous T-cell lymphoma. Ann N Y Acad Sci. 1996;795: 310-318.","DOI":"10.1111\/j.1749-6632.1996.tb52680.x"},{"key":"2019111712372670300_REF63","doi-asserted-by":"crossref","unstructured":"Rook AH, Wood GS, Yoo EK, et al. Interleukin-12 therapy of cutaneous T-cell lymphoma induces lesion regression and cytotoxic T-cell responses. Blood. 1999;94: 902-908.","DOI":"10.1182\/blood.V94.3.902.415k23_902_908"},{"key":"2019111712372670300_REF64","doi-asserted-by":"crossref","unstructured":"Rook AH, Zaki MH, Wysocka M, et al. The role for interleukin-12 therapy of cutaneous T cell lymphoma. Ann N Y Acad Sci. 2001;941: 177-184.","DOI":"10.1111\/j.1749-6632.2001.tb03721.x"}],"container-title":["Blood"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/ashpublications.org\/blood\/article-pdf\/107\/8\/3189\/1281905\/zh800806003189.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/ashpublications.org\/blood\/article-pdf\/107\/8\/3189\/1281905\/zh800806003189.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,6]],"date-time":"2023-05-06T04:40:02Z","timestamp":1683348002000},"score":1,"resource":{"primary":{"URL":"https:\/\/ashpublications.org\/blood\/article\/107\/8\/3189\/22232\/Quantitative-PCR-on-5-genes-reliably-identifies"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,4,15]]},"references-count":64,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2006,4,15]]}},"URL":"https:\/\/doi.org\/10.1182\/blood-2005-07-2813","relation":{},"ISSN":["0006-4971","1528-0020"],"issn-type":[{"value":"0006-4971","type":"print"},{"value":"1528-0020","type":"electronic"}],"subject":[],"published":{"date-parts":[[2006,4,15]]}}}